A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer.
Jana SoukupovaBarbora StastnaMadiha KanwalJan HojnyPetra ZemankovaMarianna BoreckaLeona CernaMarta CernaMonika CernaVaclava CurtisovaTatana DolezalovaPetra DuskovaLenka ForetovaOndrej HavranekKlara HorackovaMilena HovhannisyanLucie HruskovaStepan ChvojkaMarketa JanatovaMaria JanikovaSandra JelinkovaPavel JustMarta KalousovaPetra KleiblovaMarcela KosarovaMonika KoudovaJan KralMichaela KrausovaVera KrutilkovaEva MachackovaKaterina MatejkovaRenata MichalovskaPetr NehasilBarbora NemcovaJan NovotnyMatous PalekPavel PesekMarketa SafarikovaOndrej ScheinostDrahomira SpringerLenka StolarovaViktor StraneckyIvan SubrtSpiros TavandzisEva TureckovaKamila VeselaZdenka VlckovaMichal VockaTomas ZimaLibor MacůrekZdenek Kleiblnull nullPublished in: Cancer medicine (2024)
Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.